Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 143 Recruiting 113 Completed 42 Terminated 17 Not yet recruiting 11 Suspended 3 Withdrawn 2 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Educational Status 7 Standard of Care 5 Interviews as Topic 5 Cisplatin 5 Blood Specimen Collection 5 Oxaliplatin 4 Surveys and Questionnaires 3 Surgical Procedures, Operative 3 Specimen Handling 3 Patient Navigation 3 Observation 3 Nivolumab 3 Methods 3 Magnetic Resonance Imaging 3 Fluorouracil 3 Early Intervention, Educational 3 Biopsy 3 toripalimab 2 sacituzumab govitecan 2 pembrolizumab 2 lenvatinib 2 Transcutaneous Electric Nerve Stimulation 2 Radiosurgery 2 Practice Guidelines as Topic 2 Platinum Compounds 2 Paclitaxel 2 Music Therapy 2 Magnetic Resonance Spectroscopy 2 Leucovorin 2 Letrozole 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × durvalumab × 1 year × Clear all

NCT05303532 2026-05-19

ROSY-D

AstraZeneca

Phase 3 Enrolling by invitation

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡